PLA2R1 and Melnick-Needles syndrome: Classically, the literature describes idiopathic and secondary MNs, which, respectively, represent 70% and 30% of cases [5,6,7]; however, with the discovery of PLA2R antibodies, Laurence Beck, Jr.